SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001600132-16-000087
Filing Date
2016-06-21
Accepted
2016-06-21 18:17:47
Documents
1
Period of Report
2016-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_146654745382216.html 4  
1 FORM 4 wf-form4_146654745382216.xml 4 3887
  Complete submission text file 0001600132-16-000087.txt   5328
Mailing Address C/O IKARIA, INC. 6 STATE ROUTE 173 CLINTON NJ 08809
Business Address
Tasse Daniel (Reporting) CIK: 0001502785 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 161725243

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations